| P2093 | author name string | Lars Viktrup | |
| | Michael J. Detke | |
| | Beth A. Pangallo | |
| | Norman R. Zinner | |
| P2860 | cites work | Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. | Q43942529 |
| | Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial | Q43986310 |
| | Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats | Q44054332 |
| | Duloxetine versus placebo in the treatment of stress urinary incontinence | Q44062087 |
| | Duloxetine for the treatment of major depressive disorder. | Q44511365 |
| | Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary Incontinence | Q44591404 |
| | Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial | Q44756644 |
| | Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence | Q44763401 |
| | Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat | Q51597666 |
| | Detrusor-external sphincter dyssynergia: a detailed electromyographic study | Q70733712 |
| | Relationship of Symptoms of Prostatism to Commonly Used Physiological and Anatomical Measures of the Severity of Benign Prostatic Hyperplasia | Q72086795 |
| | Sertraline: a new antidepressant | Q72859620 |
| | Diabetic cystopathy presenting as primary acute urinary retention in a previously undiagnosed young male diabetic patient | Q73870555 |
| | Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis | Q73933835 |
| | The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society | Q74454469 |
| | Maximum urethral closure pressure and sphincter volume in women with urinary retention | Q77608312 |
| | The neurophysiology of urinary retention in young women and its treatment by neuromodulation | Q77617277 |
| | Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results | Q28297092 |
| | Milnacipran. A review of its use in depression | Q34067692 |
| | Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors | Q34105682 |
| | Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression | Q34155693 |
| | Tolterodine: a clinical review | Q34434859 |
| | Dual monoamine modulation for improved treatment of major depressive disorder | Q35051833 |
| | Pharmacological agents used for the treatment of stress urinary incontinence in women | Q35574096 |
| | Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers | Q35826128 |
| | Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients | Q38563305 |
| | Serotonergic facilitation of facial motoneuron excitation | Q39887089 |
| | Management of chronic pain. Part II. | Q41075401 |
| | Urinary retention with sertraline, haloperidol, and clonazepam combination. | Q42537332 |
| | Duloxetine in the long-term treatment of major depressive disorder | Q42614847 |
| P433 | issue | 2 | |
| P921 | main subject | urinary incontinence | Q281490 |
| P304 | page(s) | 65-73 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Primary Care Companion to the Journal of Clinical Psychiatry | Q15751574 |
| P1476 | title | Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence | |
| P478 | volume | 6 | |